← All stocks

Core Scientific, Inc./tx

CORZ Net selling
CIK 0001839341 #1249 in the set updated 17 Sep 2026
Bought (120 mo)
$4.22M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$39.85M
$6.05M on a plan · $0.00 straight out of an exercise
Sold at will
$33.80M
25 of 68 sales
Net
−$35.64M
−$29.59M against sales at will

By person

20 insiders · 93 transactions
93.1×

Adam Sullivan holds 93.1 times base salary in stock. $76.02M of shares against $815.77K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam Sullivan last reported holding, valued at $17.14, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Feinstein Darin
Director
$18.31M (5)
−$18.31M
32,311,470
10.06%
$553.70M
−13.7%
DUCHENE TODD M
See remarks
$10.65M (55) scheduled
−$10.65M
1,907,896
0.5937%
$32.69M
Sullivan Adam Taylor
Chief Executive Officer
$199.96K (1)
$7.43M (3)
−$7.23M
4,436,426
1.38%
$76.02M
+8,144%
Becker Todd A
Director
$410.16K (1)
$1.44M (1)
−$1.03M
195,687
0.0609%
$3.35M
+4,504%
Levy Jordan
Director
$997.04K (2)
+$997.04K
325,462
0.1013%
$5.58M
Patten Jarrod M
Director
$573.68K (8)
+$573.68K
320,448
0.0997%
$5.49M
Weiss Eric Stanton
Director
$485.75K (6)
+$485.75K
259,262
0.0807%
$4.44M
Rozov Yadin
Director
$1.44M (2)
$1.90M (1)
−$460.61K
454,162
0.1413%
$7.78M
Sterling Denise Marie Brucia
Chief Financial Officer
$110.51K (3)
−$110.51K
440,028
0.1369%
$7.54M
CRAIN ELIZABETH
Director
$109.99K (1)
+$109.99K
71,348
0.0222%
$1.22M
Minnis Matt
Director
29,453,080
9.17%
$504.71M
+1.2%
LEVITT MICHAEL J
Director
23,508,951
7.32%
$402.85M
+794.0%
Hollingsworth Jarvis V.
Director
1,211,956
0.3772%
$20.77M
+49.3%
Nygaard James P Jr
EVP, Chief Financial Officer
1,043,056
0.3246%
$17.87M
+432.1%
Neville Brian
Chief Accounting Officer
450,154
0.1401%
$7.71M
YOUNGBLOOD DR KNEELAND
Director
400,038
0.1245%
$6.86M
Olivares Stacie
Director
400,038
0.1245%
$6.86M
Booth Jeffrey David
Director
214,262
0.0667%
$3.67M
Adams Mark
Director
27,594
0.0086%
$472.86K
Smith Stephen M
Director
18,961
0.0059%
$324.92K
Insider
Date
Role
Action
Shares
Price
Amount
CRAIN ELIZABETH
20 Aug 2026
Director
Buy
6,000
$18.33
$109.99K
Weiss Eric Stanton
18 Aug 2026
Director
Buy
7,000
$19.19
$134.36K
Weiss Eric Stanton
9 Mar 2026
Director
Buy
7,000
$14.53
$101.70K
Weiss Eric Stanton
4 Nov 2025
Director
Buy
5,000
$21.50
$107.50K
Rozov Yadin
28 May 2025
Director
Buy
110,000
$10.87
$1.20M
Levy Jordan
6 Mar 2025
Director
Buy
62,500
$8.01
$500.51K
Weiss Eric Stanton
6 Mar 2025
Director
Buy
6,000
$8.46
$50.75K
Patten Jarrod M
13 Sep 2024
Director
Buy
2,240
$11.05
$24.75K
Patten Jarrod M
11 Sep 2024
Director
Buy
2,100
$10.10
$21.21K
Patten Jarrod M
10 Sep 2024
Director
Buy
2,100
$9.90
$20.79K
Weiss Eric Stanton
9 Sep 2024
Director
Buy
5,000
$9.21
$46.05K
Patten Jarrod M
4 Sep 2024
Director
Buy
7,800
$9.28
$72.38K
Patten Jarrod M
3 Sep 2024
Director
Buy
5,021
$9.68
$48.60K
Patten Jarrod M
30 Aug 2024
Director
Buy
1,500
$9.95
$14.93K
Patten Jarrod M
28 Aug 2024
Director
Buy
4,000
$9.70
$38.80K
Levy Jordan
20 Aug 2024
Director
Buy
48,700
$10.20
$496.53K
Rozov Yadin
15 Mar 2024
Director
Buy
80,000
$3.07
$245.97K
Sullivan Adam Taylor
15 Mar 2024
Chief Executive Officer
Buy
65,300
$3.06
$199.96K
Weiss Eric Stanton
15 Mar 2024
Director
Buy
15,000
$3.03
$45.40K
Becker Todd A
15 Mar 2024
Director
Buy
130,000
$3.16
$410.16K
Patten Jarrod M
15 Mar 2024
Director
Buy
100,000
$3.32
$332.22K

What was left out

Form 4 filings counted 147
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 43
Sales straight out of an exercise 0
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 261,434,781
Sales filed before the plan box existed 5
History held since 1 Jun 2022